The effect of metabolic syndrome on head and neck cancer incidence risk: a population-based prospective cohort study
- PMID: 34082811
- PMCID: PMC8173864
- DOI: 10.1186/s40170-021-00261-w
The effect of metabolic syndrome on head and neck cancer incidence risk: a population-based prospective cohort study
Abstract
Background: There are limited evidences clarifying the impact of metabolic syndrome (MS) and its components on head and neck cancer (HNC) incidence risk. We explored the correlation between MS, MS components, and the combined effects of MS and C-reactive protein (CRP) and HNC risk.
Methods: This is a prospective analysis of 474,929 participants from the UK Biobank cohort. Cox proportional hazard regression was utilized to assess the hazard ratio (HR) and 95% confidence interval (CI) and to explore the non-linear correlation between an individual MS component and HNC risk.
Results: Individuals with MS (HR, 1.05; 95%CI, 0.90-1.22) had no higher HNC risk than those without MS. More MS components showed no higher HNC risk. Nevertheless, hyperglycemia (HR, 1.22; 95%CI, 1.02-1.45) was independently correlated with elevated HNC risk. In a non-linear manner, waist circumference and high-density lipoprotein cholesterol (HDL-C) showed a U-shaped association with HNC risk. Further, piecewise linear model analysis indicated that higher male waist circumference, female waist circumference (≥93.16 cm), blood glucose (≥4.70 mmol/L) and male HDL-C (≥1.26mmo/L), and lower male HDL-C (<1.26mmo/L) were correlated with higher HNC risk. Increased CRP (≥1.00mg/dL) elevated HNC risk and individuals with MS and CRP≥1.00mg/dL had the highest HNC risk (HR, 1.29; 95%CI, 1.05-1.58). But no joint effect between MS and CRP was detected (p-interaction=0.501).
Conclusions: MS are not correlated with elevated HNC risk. High waist circumference and blood glucose are independent risk factor of HNC incidence. Controlling HDL-C in an appropriate range can get the lowest risk of male HNC. No joint effect of MS and CRP exists in HNC tumorigenesis.
Keywords: C-reactive protein; Head and neck cancer; Metabolic syndrome; Metabolic syndrome components.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures

Similar articles
-
Metabolic syndrome and its component traits present gender-specific association with liver cancer risk: a prospective cohort study.BMC Cancer. 2021 Oct 7;21(1):1084. doi: 10.1186/s12885-021-08760-1. BMC Cancer. 2021. PMID: 34620113 Free PMC article.
-
Metabolic syndrome and risk of pancreatic cancer: A population-based prospective cohort study.Int J Cancer. 2020 Dec 15;147(12):3384-3393. doi: 10.1002/ijc.33172. Epub 2020 Jul 29. Int J Cancer. 2020. PMID: 32580250
-
Anthropometry and head and neck cancer:a pooled analysis of cohort data.Int J Epidemiol. 2015 Apr;44(2):673-81. doi: 10.1093/ije/dyv059. Epub 2015 Jun 6. Int J Epidemiol. 2015. PMID: 26050257 Free PMC article.
-
Metabolic Syndrome Is Associated With an Increased Risk of Rheumatoid Arthritis: A Prospective Cohort Study Including 369,065 Participants.J Rheumatol. 2024 Apr 1;51(4):360-367. doi: 10.3899/jrheum.2023-0349. J Rheumatol. 2024. PMID: 38224984
-
[Association between C-reactive protein level and metabolic syndrome and components thereof].Zhonghua Yi Xue Za Zhi. 2006 Aug 15;86(30):2105-9. Zhonghua Yi Xue Za Zhi. 2006. PMID: 17064612 Chinese.
Cited by
-
Lipid metabolism reprogramming in head and neck cancer.Front Oncol. 2023 Oct 20;13:1271505. doi: 10.3389/fonc.2023.1271505. eCollection 2023. Front Oncol. 2023. PMID: 37927468 Free PMC article. Review.
-
Metabolic Diseases and Risk of Head and Neck Cancer: A Cohort Study Analyzing Nationwide Population-Based Data.Cancers (Basel). 2022 Jul 4;14(13):3277. doi: 10.3390/cancers14133277. Cancers (Basel). 2022. PMID: 35805048 Free PMC article.
-
Association between Metabolic Syndrome and Risk of Hypopharyngeal Cancer: A Nationwide Cohort Study from Korea.Cancers (Basel). 2023 Sep 7;15(18):4454. doi: 10.3390/cancers15184454. Cancers (Basel). 2023. PMID: 37760423 Free PMC article.
-
Exploring genes associated with metabolic dysfunction as therapeutic targets for head and neck cancers: a novel strategy.Int J Surg. 2025 Apr 1;111(4):3129-3134. doi: 10.1097/JS9.0000000000002293. Int J Surg. 2025. PMID: 39907620 Free PMC article.
-
Impact of statin use in head and neck cancer: a nested case-control study.Eur Arch Otorhinolaryngol. 2025 Mar;282(3):1443-1457. doi: 10.1007/s00405-024-09020-1. Epub 2024 Oct 23. Eur Arch Otorhinolaryngol. 2025. PMID: 39441362
References
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous